Literature DB >> 15735228

Replacement of valsartan and candesartan by telmisartan in hypertensive patients with type 2 diabetes: metabolic and antiatherogenic consequences.

Yoshitaka Miura, Naoki Yamamoto, Shin Tsunekawa, Seiko Taguchi, Yoko Eguchi, Nobuaki Ozaki, Yutaka Oiso.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15735228     DOI： 10.2337/diacare.28.3.757

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  22 in total

Review 1.  Drug-induced endocrine and metabolic disorders.

Authors:  Ronald C W Ma; Alice P S Kong; Norman Chan; Peter C Y Tong; Juliana C N Chan
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 2.  Telmisartan: a review of its use in cardiovascular disease prevention.

Authors:  James E Frampton
Journal:  Drugs       Date:  2011-04-16       Impact factor: 9.546

3.  Metabolic effects of telmisartan in spontaneously hypertensive rats.

Authors:  Yong-Qi Li; Hui Ji; Yi-Hua Zhang; Da-Yong Ding; Xiao-Lei Ye
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-05-20       Impact factor: 3.000

4.  Telmisartan inhibits AGE-induced C-reactive protein production through downregulation of the receptor for AGE via peroxisome proliferator-activated receptor-gamma activation.

Authors:  T Yoshida; S Yamagishi; K Nakamura; T Matsui; T Imaizumi; M Takeuchi; H Koga; T Ueno; M Sata
Journal:  Diabetologia       Date:  2006-09-27       Impact factor: 10.122

5.  The Possible Role of the Angiotensin System in the Pathophysiology of Schizophrenia: Implications for Pharmacotherapy.

Authors:  SeungJu Jackie Oh; Xiaoduo Fan
Journal:  CNS Drugs       Date:  2019-06       Impact factor: 5.749

6.  Beneficial cardiometabolic actions of telmisartan plus amlodipine therapy in elderly patients with poorly controlled hypertension.

Authors:  Hisatoshi Bekki; Kiichiro Yamamoto; Masayoshi Sone; Tomoki Homma; Masashi Nakata; Masatoshi Nohara; Kei Fukami; Seiya Okuda; Sho-ichi Yamagishi
Journal:  Clin Cardiol       Date:  2011-02-01       Impact factor: 2.882

Review 7.  New standards in hypertension and cardiovascular risk management: focus on telmisartan.

Authors:  Domenico Galzerano; Cristina Capogrosso; Sara Di Michele; Antonio Galzerano; Paola Paparello; Diana Lama; Carlo Gaudio
Journal:  Vasc Health Risk Manag       Date:  2010-03-24

8.  Combination therapy in hypertension: An update.

Authors:  Sanjay Kalra; Bharti Kalra; Navneet Agrawal
Journal:  Diabetol Metab Syndr       Date:  2010-06-24       Impact factor: 3.320

9.  The effect of adjunctive telmisartan treatment on psychopathology and cognition in patients with schizophrenia.

Authors:  X Fan; X Song; M Zhao; L F Jarskog; R Natarajan; N Shukair; O Freudenreich; D C Henderson; D C Goff
Journal:  Acta Psychiatr Scand       Date:  2017-08-29       Impact factor: 6.392

Review 10.  The effect of angiotensin receptor blockers on C-reactive protein and other circulating inflammatory indices in man.

Authors:  Alessandra Del Fiorentino; Silvana Cianchetti; Alessandro Celi; Giulia Dell'Omo; Roberto Pedrinelli
Journal:  Vasc Health Risk Manag       Date:  2009-04-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.